Source comparison
Side-by-Side Comparison
Mechanism Ghrelin receptor (GHSR) agonist; stimulates endogenous GH Exogenous recombinant human growth hormone Evidence Grade B+ A+ Route Oral (capsule or liquid) Subcutaneous injection Typical Dose 10 - 25 mg/day oral 1 - 4 IU/day SC injection Half-Life ~24 h
This comparison does not assign a generated winner or score.
- Mechanism
- Ghrelin receptor (GHSR) agonist; stimulates endogenous GH
- Exogenous recombinant human growth hormone
- Evidence Grade
- B+
- A+
- Route
- Oral (capsule or liquid)
- Subcutaneous injection
- Typical Dose
- 10 - 25 mg/day oral
- 1 - 4 IU/day SC injection
- Half-Life
- ~24 hours
- ~3-4 hours (GH clearance)
- IGF-1 Increase
- 40 - 90% above baseline
- 100 - 300%+ (dose-dependent)
- GH Release Pattern
- Amplified pulsatile (endogenous)
- Direct exogenous bolus
- Best For
- Budget GH optimization, sleep, appetite
- Maximum GH elevation, precise dosing, anti-aging
- FDA Status
- Not FDA-approved; investigational
- FDA-approved (GH deficiency)
- Cost (monthly)
- $30 - $60
- $300 - $1,000+